ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1589 | Unknown status | CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients | COVID-19 Respiratory Infection | Drug: PD-1 and ACE2 Knockout T Cells Drug: PD-1 and ACE2 Knockout T Cells Drug: PD-1 and ACE2 Knockout T Cells |
Phase 2 | Mahmoud Ramadan mohamed Elkazzaz | OTHER | 16 | All | 18 Years ~ 70 Years | |
1588 | Completed | Crizanlizumab for Treating COVID-19 Vasculopathy | COVID-19 | Drug: Crizanlizumab Other: 0.9% saline |
Phase 2 | Johns Hopkins University, Novartis, Socar Research SA, Brigham and Women's Hospital | OTHER | 54 | All | 18 Years | Johns Hopkins Hospital, Baltimore, Maryland, United States |
1587 | Recruiting | Cromolyn Sodium for Treatment of COVID-19 Pneumonia | Pneumonia, Viral | Drug: Cromolyn Sodium Other: Placebo |
Phase 3 | Texas Tech University Health Sciences Center, El Paso | OTHER | 60 | All | 18 Years ~ 80 Years | University Medical Center of El Paso, El Paso, Texas, United States |
1586 | Completed | CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION | COVID 19 | Drug: MR or M-M-R II ® vaccine Drug: Placebo |
Phase 3 | Washington University School of Medicine, COVID -19 Therapeutics Accelerator | OTHER | 3411 | All | 18 Years | Washington University School of Medicine, Saint Louis, Missouri, United States University of Ghana Medical Centre, Accra, Greater Accra Region, Ghana Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray, Cape Town, South Africa Masiphumelele, Desmond Tutu Health Foundation, Sunnydale, Cape Town, South Africa JOSHA Research, Bloemfontein, Free State, South Africa Wits RHI, University of the Witwatersrand, Hillbrow, Johannesburg,Gauteng, South Africa Clinical HIV Research Unit (CHRU), Auckland Park, Johannesburg, South Africa Perinatal HIV Research Unit (PHRU), Diepkloof, Johannesburg, South Africa Setshaba Research Centre, Soshanguve, Tshwane, South Africa Groote Schuur Hospital, Cape Town, Western Cape, South Africa FAMCRU (Family Clinical Research with Ubuntu), Cape Town, South Africa Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth, South Africa Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa Aurum Institute Tembisa, Tembisa, South Africa University College London, London, United Kingdom Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia |
1585 | Withdrawn | CSL324 in COVID-19 | Coronavirus Disease 2019 (COVID-19) | Biological: CSL324 Drug: Placebo |
Phase 2 | CSL Behring | INDUSTRY | 0 | All | 18 Years | |
1584 | Unknown status | Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | ARDS, Human | Drug: poractant alfa | Phase 2 | Dr Christophe LENCLUD | OTHER | 20 | All | 18 Years ~ 100 Years | CH Francois Quesnay, Mantes la Jolie, France |
1583 | Unknown status | Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia | COVID 19 Pneumonia | Drug: Cyclosporin A | Phase 2 | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | OTHER_GOV | 200 | All | 18 Years | Jose Luis Jl Galvez-Romero, Puebla, Mexico |